Atosiban (free acid) Trifluoroacetate

Atosiban (free acid) Trifluoroacetate is a synthetic peptide compound designed to function as an oxytocin and vasopressin receptor antagonist. Structurally, it is a cyclic nonapeptide, and the inclusion of the trifluoroacetate counterion facilitates its formulation and handling in research environments. The compound's primary biochemical relevance lies in its high specificity for the oxytocin receptor, as well as its ability to modulate vasopressin-mediated pathways. This dual antagonistic profile has made it a valuable molecular tool in the investigation of peptide hormone signaling, receptor pharmacology, and the physiological roles of oxytocin and vasopressin in various biological systems.

Receptor binding assays: Atosiban is frequently employed in receptor binding studies to quantitatively assess the affinity and selectivity of ligands for oxytocin and vasopressin receptors. By functioning as a competitive antagonist, it enables researchers to delineate the binding characteristics of these receptors in tissue preparations, cell-based assays, or membrane fractions. Such applications are fundamental for characterizing receptor-ligand interactions, mapping binding sites, and supporting the development of novel receptor modulators.

Signal transduction research: The compound is widely used to dissect downstream signaling pathways activated by oxytocin and vasopressin receptors. By inhibiting receptor activation, it allows for controlled studies of G protein-coupled receptor (GPCR) signaling cascades, including second messenger production, calcium mobilization, and kinase activation. This approach is essential for elucidating the molecular mechanisms underlying peptide hormone action and for distinguishing receptor-specific effects in complex biological systems.

Functional studies in smooth muscle physiology: Atosiban serves as a critical tool in functional assays examining the contractile responses of smooth muscle tissues, particularly in the uterus and vascular system. Researchers utilize its antagonistic properties to investigate the contribution of oxytocin and vasopressin signaling to muscle tone regulation, contraction dynamics, and tissue responsiveness under various experimental conditions. These studies provide mechanistic insights into the physiological roles of peptide hormones in reproductive and vascular biology.

Pharmacological profiling: The compound is integral to the pharmacological characterization of novel compounds targeting the oxytocin and vasopressin receptor families. It is commonly used as a reference antagonist in competitive binding and functional activity assays, enabling the comparison of new ligands' potency, efficacy, and selectivity. Such profiling supports drug discovery efforts and advances the understanding of receptor subtype pharmacology.

Peptide synthesis and analytical method development: Atosiban (free acid) Trifluoroacetate is also utilized as a reference material in peptide synthesis optimization and in the development of analytical methods for peptide quantification and characterization. Its defined structure and receptor specificity make it a suitable standard for validating chromatographic, spectrometric, or immunoassay techniques, thereby ensuring accuracy and reliability in peptide research workflows.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists